
When Kasim Kutay took over as CEO of Novo Holdings in 2016, the company’s total assets were value under EUR 40bn. Now, five and a half years later, Novo Holding’s assets have reached a value of over EU90bn.
As CEO, Kutay’s results have benefitted greatly from pharmaceutical firm Novo Nordisk’s success, but Novo Holding has more than just a significantly larger investment portfolio today, as departments from US to China have now been established, with more on the way.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app